Australia's Clarity Pharmaceuticals hits 10-month low on bigger HY loss

Clarity Pharmaceuticals

03/03/2025 03:48

** Shares of Clarity Pharmaceuticals CU6.AX down 15% to A$3.025, top losers on the S&P/ASX 200 .AXJO benchmark index

** Stock falls as much as 26% to A$2.644 earlier in the day, their lowest level since April 30, 2024

** Radiopharmaceutical co said on Friday HY loss attributable widened to A$23 mln ($14.30 mln) from A$17 mln a year earlier

** Five mln shares change hands, 3.4 times the 30-day average of 1.5 mln

** Stock down 27.6% YTD, including current session's moves

($1 = 1.6080 Australian dollars)

 (Reporting by Manasi Dasa in Bengaluru)

 ((Manasi.DasaSundeep@thomsonreuters.com;))